Next Article in Journal
Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty®)
Next Article in Special Issue
Potential Adjuvant Therapeutic Effect of Lactobacillus plantarum Probio-88 Postbiotics against SARS-COV-2
Previous Article in Journal
Functional NK Cell Activation by Ovalbumin Immunization with a Monophosphoryl Lipid A and Poly I:C Combination Adjuvant Promoted Dendritic Cell Maturation
Previous Article in Special Issue
Cost–Benefit Analysis of a Mass Vaccination Strategy to Control Brucellosis in Sheep and Goats in Northern Iraq
Article

Cost-Effectiveness of Three Poliovirus Immunization Schedules in Shanghai, China

1
Shanghai Municipal Center for Disease Control and Prevention, Institute of Immunization, Shanghai 200336, China
2
Ministry of Education Key Laboratory of Public Health Safety, Department of Epidemiology, School of Public Health, Fudan University, Shanghai 200032, China
*
Author to whom correspondence should be addressed.
Academic Editors: Ifran A. Rather, Suriya Rehman, Yan Yan Hor and Lew Lee Ching
Vaccines 2021, 9(10), 1062; https://doi.org/10.3390/vaccines9101062
Received: 24 August 2021 / Revised: 18 September 2021 / Accepted: 19 September 2021 / Published: 23 September 2021
In Shanghai, China, a polio immunization schedule of four inactivated polio vaccines (IPV) has been implemented since 2020, replacing the schedules of a combination of two IPVs and two bivalent live attenuated oral polio vaccines (bOPV), and four trivalent live attenuated oral polio vaccines (tOPV). This study aimed to assess the cost-effectiveness of these three schedules in infants born in 2016, in preventing vaccine-associated paralytic poliomyelitis (VAPP). We performed a decision tree model and estimated incremental cost-effectiveness ratio (ICER). Compared to the four-tOPV schedule, the two-IPV-two-bOPV schedule averted 1.2 VAPP cases and 16.83 disability-adjusted life years (DALY) annually; while the four-IPV schedule averted 1.35 VAPP cases and 18.96 DALY annually. Consequently, ICERVAPP and ICERDALY were substantially high for two-IPV-two-bOPV (CNY 12.96 million and 0.93 million), and four-IPV (CNY 21.24 million and 1.52 million). Moreover, net monetary benefit of the two-IPV-two-bOPV and four-IPV schedules was highest when the cost of IPV was hypothesized to be less than CNY 23.75 or CNY 9.11, respectively, and willingness-to-pay was hypothesized as CNY 0.6 million in averting one VAPP-induced DALY. IPV-containing schedules are currently cost-ineffective in Shanghai. They may be cost-effective by reducing the prices of IPV, which may accelerate polio eradication in Chinese settings. View Full-Text
Keywords: poliomyelitis; poliovirus; live attenuated oral polio vaccine; inactivated polio vaccine; cost-effectiveness analysis; cost-benefit analysis poliomyelitis; poliovirus; live attenuated oral polio vaccine; inactivated polio vaccine; cost-effectiveness analysis; cost-benefit analysis
Show Figures

Figure 1

MDPI and ACS Style

Ren, J.; Maimaiti, H.; Sun, X.; Huang, Z.; Liu, J.; Yang, J.; Li, Z.; Bai, Q.; Lu, Y. Cost-Effectiveness of Three Poliovirus Immunization Schedules in Shanghai, China. Vaccines 2021, 9, 1062. https://doi.org/10.3390/vaccines9101062

AMA Style

Ren J, Maimaiti H, Sun X, Huang Z, Liu J, Yang J, Li Z, Bai Q, Lu Y. Cost-Effectiveness of Three Poliovirus Immunization Schedules in Shanghai, China. Vaccines. 2021; 9(10):1062. https://doi.org/10.3390/vaccines9101062

Chicago/Turabian Style

Ren, Jia, Hairenguli Maimaiti, Xiaodong Sun, Zhuoying Huang, Jiechen Liu, Jianping Yang, Zhi Li, Qingrui Bai, and Yihan Lu. 2021. "Cost-Effectiveness of Three Poliovirus Immunization Schedules in Shanghai, China" Vaccines 9, no. 10: 1062. https://doi.org/10.3390/vaccines9101062

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop